Published online Jan 28, 2021. doi: 10.4329/wjr.v13.i1.19
Peer-review started: November 23, 2020
First decision: December 7, 2020
Revised: December 13, 2020
Accepted: December 22, 2020
Article in press: December 22, 2020
Published online: January 28, 2021
Processing time: 64 Days and 21.1 Hours
Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Systemic complications include cardiovascular, neurological, hepatic, renal and altered coagulation. Derangements in haemostasis with SARS-CoV-2 infection have been termed COVID-19 associated coagulopathy (CAC). CAC is postulated to be one of the significant causes for sudden deaths in this pandemic, with infection of endothelial cells and subsequent endotheliitis through angiotensin-converting enzyme-2 receptors playing a key role in the pathogenesis. In this pictorial review, we describe the imaging findings in a multitude of extrapulmonary arterial (aorta, cerebral, mesenteric, renal and peripheral arterial system) and venous thrombotic phenomena detected on contrast-enhanced computed tomography and magnetic resonance imaging of COVID-19 patients which could not be attributed to any other causes. Knowledge of incidence of these complications, lowering the threshold for diagnostic imaging in symptomatic patients and timely radiological detection can play a vital role in subsequent management of these critically ill patients.
Core Tip: Coronavirus disease 2019 (COVID-19) disease is a systemic illness with multi-organ system manifestations. Coagulopathy in the setting of COVID-19 has a unique pathophysiology with a propensity for both arterial and venous thrombosis. These phenomena may be clinically occult with imaging playing a vital role in detection and management. A high degree of clinical suspicion with a low threshold for cross sectional imaging can positively alter outcomes during this ongoing pandemic.